This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Lasse Leino, PhD
Chief Executive Officer, Adjunct Professor at DelSiTech Ltd.


Dr. Lasse Leino started his career in pharma industry almost for 20 years ago in Astra Zeneca in Sweden, moved then to Finland and had several managerial R&D positions in biotech and pharma companies. In 2005 he became a bio-entrepreneur and CEO of two drug development companies that were later merged and listed in the First North List in Helsinki Stock Exchange. Since 2013 he has been the Chief Executive Officer of a Finland-based drug delivery technology company DelSiTech Ltd.  Dr. Leino has a PhD in biochemistry and holds also a position as Adjunct Professor at the University of Turku, Finland.

Agenda Sessions

  • Long-acting Injectable Peptide Formulations Based on Biodegradable Silica


Speakers at this event